Cooper Companies | COO - Interest Expense On Debt

Stock Price
64.42
Daily Change
-0.53 -0.82%
Monthly
-9.84%
Yearly
-20.36%
Q2 Forecast
63.04

Cooper Companies reported $22.4M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Abbott USD 68M 26M Mar/2026
Align Technology USD 2M 660K Mar/2023
AtriCure USD 1.33M 17K Sep/2025
Avanos Medical USD 1.9M 100K Dec/2025
Bausch Health Companies USD 412M 53M Sep/2025
Baxter International USD 58M 14M Sep/2025
Bayer EUR 675M 87M Dec/2025
Becton, Dickinson and Co. USD 153M 2M Dec/2025
Boston Scientific USD 90M 0 Mar/2026
Cooper Companies USD 22.4M 2M Dec/2025
Dentsply International USD 22M 1000K Dec/2025
Dexcom USD 4.7M 0 Sep/2025
Edwards Lifesciences USD 35.9M 2.7M Dec/2025
Globus Medical USD 17K 5.1B Dec/2025
Haemonetics USD 7.21M 3.14M Sep/2025
Inogen 1.03M 384K Mar/2025
Insulet USD 9.2M 2.2M Dec/2025
Integra LifeSciences USD 23.67M 953K Dec/2025
Intuitive Surgical USD 20.11B 58.39B Mar/2026
J&J USD 43M 25M Mar/2026
Medtronic USD 181M 0 Dec/2025
Merit Medical Systems USD 6.36M 390K Dec/2025
Novartis USD 281M 8M Sep/2025
ResMed USD 8.79M 14.55M Sep/2025
STAAR Surgical USD 800K 799K Sep/2025
Steris USD 14.9M 0 Dec/2025
Stryker USD 157M 46.17B Sep/2025
Tandem Diabetes Care USD 2.07M 872.58M Dec/2025
Teleflex USD 28.15M 3.69M Dec/2025
Zimmer Biomet Holdings USD 71.9M 3.5M Dec/2025